Nitrates Updated: Current Use in Angina, Ischemia, Infarction and Failure
Nitrates remain among the most commonly used therapeutic agents in cardiology. That they can re lieve pain in angina pectoris has been known at least since 1867, when Lauder Brunton described their clinical use. Now, almost 130 years later, we are constantly learning more about their optimal use in...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Boston, MA
Springer US
1997
|
Schlagworte: | |
Online-Zugang: | UBR01 URL des Erstveröffentlichers |
Zusammenfassung: | Nitrates remain among the most commonly used therapeutic agents in cardiology. That they can re lieve pain in angina pectoris has been known at least since 1867, when Lauder Brunton described their clinical use. Now, almost 130 years later, we are constantly learning more about their optimal use in anginal syndromes. For example, there is no doubt that nitrate tolerance occurs, but equally no doubt that certain drug dosages help to attenuate such toler ance. Thus, our understanding of nitrate tolerance has been taken further by the advent of new nitrate preparations and by studies at a basic science level. The current intense interest in nitrates has been rekindled by the growing emphasis on the role of the endothelium in the production of nitric oxide, a basic cardiovascular regulator. If nitric oxide is vasodilator and protects the vascular endothelium, then nitrates should also have similar properties. Hence this book starts off with the role of the endothelium and ni trates in vasodilation. Next, the mechanisms of ac tion of nitrates are considered with emphasis on the role of cyclic GMP. The chief limitation to the use of nitrates lies in nitrate tolerance. After carefully looking at all the evidence, the authors of the third chapter conclude that the mechanism is likely to be multifactorial. The mechanism responsible for the tolerance still remains unknown. In vitro tolerance may be due to enhanced production of vascular superoxide [1] |
Beschreibung: | 1 Online-Ressource (X, 226 p) |
ISBN: | 9781461311355 |
DOI: | 10.1007/978-1-4613-1135-5 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046146373 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1997 |||| o||u| ||||||eng d | ||
020 | |a 9781461311355 |9 978-1-4613-1135-5 | ||
024 | 7 | |a 10.1007/978-1-4613-1135-5 |2 doi | |
035 | |a (ZDB-2-SME)978-1-4613-1135-5 | ||
035 | |a (OCoLC)1118995006 | ||
035 | |a (DE-599)BVBBV046146373 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.12 |2 23 | |
084 | |a XI 4303 |0 (DE-625)153005:12909 |2 rvk | ||
245 | 1 | 0 | |a Nitrates Updated |b Current Use in Angina, Ischemia, Infarction and Failure |c edited by Udho Thadani, Lionel H. Opie |
264 | 1 | |a Boston, MA |b Springer US |c 1997 | |
300 | |a 1 Online-Ressource (X, 226 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a Nitrates remain among the most commonly used therapeutic agents in cardiology. That they can re lieve pain in angina pectoris has been known at least since 1867, when Lauder Brunton described their clinical use. Now, almost 130 years later, we are constantly learning more about their optimal use in anginal syndromes. For example, there is no doubt that nitrate tolerance occurs, but equally no doubt that certain drug dosages help to attenuate such toler ance. Thus, our understanding of nitrate tolerance has been taken further by the advent of new nitrate preparations and by studies at a basic science level. The current intense interest in nitrates has been rekindled by the growing emphasis on the role of the endothelium in the production of nitric oxide, a basic cardiovascular regulator. If nitric oxide is vasodilator and protects the vascular endothelium, then nitrates should also have similar properties. Hence this book starts off with the role of the endothelium and ni trates in vasodilation. Next, the mechanisms of ac tion of nitrates are considered with emphasis on the role of cyclic GMP. The chief limitation to the use of nitrates lies in nitrate tolerance. After carefully looking at all the evidence, the authors of the third chapter conclude that the mechanism is likely to be multifactorial. The mechanism responsible for the tolerance still remains unknown. In vitro tolerance may be due to enhanced production of vascular superoxide [1] | ||
650 | 4 | |a Cardiology | |
650 | 4 | |a Cardiology | |
650 | 0 | 7 | |a Nitrattherapie |0 (DE-588)4137903-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Herzkrankheit |0 (DE-588)4024663-2 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Herzkrankheit |0 (DE-588)4024663-2 |D s |
689 | 0 | 1 | |a Nitrattherapie |0 (DE-588)4137903-2 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Thadani, Udho |4 edt | |
700 | 1 | |a Opie, Lionel H. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461284345 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792334668 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461311362 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4613-1135-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031526558 | ||
966 | e | |u https://doi.org/10.1007/978-1-4613-1135-5 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180484257742848 |
---|---|
any_adam_object | |
author2 | Thadani, Udho Opie, Lionel H. |
author2_role | edt edt |
author2_variant | u t ut l h o lh lho |
author_facet | Thadani, Udho Opie, Lionel H. |
building | Verbundindex |
bvnumber | BV046146373 |
classification_rvk | XI 4303 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-4613-1135-5 (OCoLC)1118995006 (DE-599)BVBBV046146373 |
dewey-full | 616.12 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.12 |
dewey-search | 616.12 |
dewey-sort | 3616.12 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-4613-1135-5 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03329nmm a2200505zc 4500</leader><controlfield tag="001">BV046146373</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1997 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461311355</subfield><subfield code="9">978-1-4613-1135-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4613-1135-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4613-1135-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118995006</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146373</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4303</subfield><subfield code="0">(DE-625)153005:12909</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nitrates Updated</subfield><subfield code="b">Current Use in Angina, Ischemia, Infarction and Failure</subfield><subfield code="c">edited by Udho Thadani, Lionel H. Opie</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 226 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Nitrates remain among the most commonly used therapeutic agents in cardiology. That they can re lieve pain in angina pectoris has been known at least since 1867, when Lauder Brunton described their clinical use. Now, almost 130 years later, we are constantly learning more about their optimal use in anginal syndromes. For example, there is no doubt that nitrate tolerance occurs, but equally no doubt that certain drug dosages help to attenuate such toler ance. Thus, our understanding of nitrate tolerance has been taken further by the advent of new nitrate preparations and by studies at a basic science level. The current intense interest in nitrates has been rekindled by the growing emphasis on the role of the endothelium in the production of nitric oxide, a basic cardiovascular regulator. If nitric oxide is vasodilator and protects the vascular endothelium, then nitrates should also have similar properties. Hence this book starts off with the role of the endothelium and ni trates in vasodilation. Next, the mechanisms of ac tion of nitrates are considered with emphasis on the role of cyclic GMP. The chief limitation to the use of nitrates lies in nitrate tolerance. After carefully looking at all the evidence, the authors of the third chapter conclude that the mechanism is likely to be multifactorial. The mechanism responsible for the tolerance still remains unknown. In vitro tolerance may be due to enhanced production of vascular superoxide [1]</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nitrattherapie</subfield><subfield code="0">(DE-588)4137903-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nitrattherapie</subfield><subfield code="0">(DE-588)4137903-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thadani, Udho</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Opie, Lionel H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461284345</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792334668</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461311362</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4613-1135-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526558</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4613-1135-5</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV046146373 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:29Z |
institution | BVB |
isbn | 9781461311355 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526558 |
oclc_num | 1118995006 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (X, 226 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1997 |
publishDateSearch | 1997 |
publishDateSort | 1997 |
publisher | Springer US |
record_format | marc |
spelling | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure edited by Udho Thadani, Lionel H. Opie Boston, MA Springer US 1997 1 Online-Ressource (X, 226 p) txt rdacontent c rdamedia cr rdacarrier Nitrates remain among the most commonly used therapeutic agents in cardiology. That they can re lieve pain in angina pectoris has been known at least since 1867, when Lauder Brunton described their clinical use. Now, almost 130 years later, we are constantly learning more about their optimal use in anginal syndromes. For example, there is no doubt that nitrate tolerance occurs, but equally no doubt that certain drug dosages help to attenuate such toler ance. Thus, our understanding of nitrate tolerance has been taken further by the advent of new nitrate preparations and by studies at a basic science level. The current intense interest in nitrates has been rekindled by the growing emphasis on the role of the endothelium in the production of nitric oxide, a basic cardiovascular regulator. If nitric oxide is vasodilator and protects the vascular endothelium, then nitrates should also have similar properties. Hence this book starts off with the role of the endothelium and ni trates in vasodilation. Next, the mechanisms of ac tion of nitrates are considered with emphasis on the role of cyclic GMP. The chief limitation to the use of nitrates lies in nitrate tolerance. After carefully looking at all the evidence, the authors of the third chapter conclude that the mechanism is likely to be multifactorial. The mechanism responsible for the tolerance still remains unknown. In vitro tolerance may be due to enhanced production of vascular superoxide [1] Cardiology Nitrattherapie (DE-588)4137903-2 gnd rswk-swf Herzkrankheit (DE-588)4024663-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Herzkrankheit (DE-588)4024663-2 s Nitrattherapie (DE-588)4137903-2 s DE-604 Thadani, Udho edt Opie, Lionel H. edt Erscheint auch als Druck-Ausgabe 9781461284345 Erscheint auch als Druck-Ausgabe 9780792334668 Erscheint auch als Druck-Ausgabe 9781461311362 https://doi.org/10.1007/978-1-4613-1135-5 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure Cardiology Nitrattherapie (DE-588)4137903-2 gnd Herzkrankheit (DE-588)4024663-2 gnd |
subject_GND | (DE-588)4137903-2 (DE-588)4024663-2 (DE-588)4143413-4 |
title | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure |
title_auth | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure |
title_exact_search | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure |
title_full | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure edited by Udho Thadani, Lionel H. Opie |
title_fullStr | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure edited by Udho Thadani, Lionel H. Opie |
title_full_unstemmed | Nitrates Updated Current Use in Angina, Ischemia, Infarction and Failure edited by Udho Thadani, Lionel H. Opie |
title_short | Nitrates Updated |
title_sort | nitrates updated current use in angina ischemia infarction and failure |
title_sub | Current Use in Angina, Ischemia, Infarction and Failure |
topic | Cardiology Nitrattherapie (DE-588)4137903-2 gnd Herzkrankheit (DE-588)4024663-2 gnd |
topic_facet | Cardiology Nitrattherapie Herzkrankheit Aufsatzsammlung |
url | https://doi.org/10.1007/978-1-4613-1135-5 |
work_keys_str_mv | AT thadaniudho nitratesupdatedcurrentuseinanginaischemiainfarctionandfailure AT opielionelh nitratesupdatedcurrentuseinanginaischemiainfarctionandfailure |